HCV Screening & Assessments
Pretreatment Assessments
AASLD/IDSA: Simplified HCV Treatment Guidelines
Eligibility, recommended therapies, and monitoring steps for effective HCV treatment in adults new to therapy
Pretreatment Assessment Guide
AASLD/IDSA guidance on HCV screening, diagnosis, treatment, and management
Pretreatment Laboratory Assessments
AASLD/IDSA recommendations for pretreatment assessments following an HCV diagnosis
Hepatitis B Reactivation Guide
HBV reactivation causes, complications, assessments, and treatment considerations for patients with HCV/HBV coinfection
Assessing Liver Damage Caused by HCV Infection: Common Laboratory Tests
Assessments to be conducted within 6 months prior to starting HCV treatment
Liver Damage Assessments to Identify Patients for Simplified HCV Treatment
Noninvasive techniques that can be used to assess liver damage
Identifying and Managing Patients Without Cirrhosis
The degree of hepatic fibrosis is key to determining the initial and follow-up management of patients
Identifying and Managing Patients With Cirrhosis
The differences between compensated and decompensated cirrhosis, how to measure the severity, and AASLD/IDSA guidelines
HCV Diagnosis and Assessments: Anthony Martinez and Tipu Khan
Learn about pretreatment assessments, liver fibrosis progression, and liver damage evaluation
AASLD/IDSA: Guidelines for Monitoring HCV Patients
Monitoring patients who are starting HCV treatment, are on treatment, or have completed therapy
